Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-(3,4-dihydroxyphenyl)ethyl (2s-(2alpha,3e,4beta))-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetate
2. Oleoeuropein
3. Oleoeuropeine
1. 32619-42-4
2. Oleoeuropein
3. Oleoeuropeine
4. 2-(3,4-dihydroxyphenyl)ethyl (2s-(2alpha,3e,4beta))-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetate
5. Methyl (4s,5e,6s)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl]-5-ethylidene-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4h-pyran-3-carboxylate
6. 2o4553545l
7. 2h-pyran-4-acetic Acid, 3-ethylidene-2-(.beta.-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(3,4-dihydroxyphenyl)ethyl Ester, (2s,3e,4s)-
8. Methyl (2s,3e,4s)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-5-carboxylate
9. Einecs 251-129-6
10. Oleuroperin
11. Unii-2o4553545l
12. Oleuropein [mi]
13. Oleuropein [inci]
14. Oleuropein [vandf]
15. Oleuropein, >=98.0%
16. Oleuropein [usp-rs]
17. Oleuropein [who-dd]
18. Oleuropein, Analytical Standard
19. Chebi:7747
20. Megxp0_000369
21. Schembl4306969
22. Chembl1911053
23. Oleuropein, >=80% (hplc)
24. Acon1_000443
25. Gtpl11027
26. Dtxsid60905103
27. Hy-n0292
28. Zinc4098348
29. Mfcd16879008
30. Akos015900702
31. Ccg-269961
32. Ncgc00169074-01
33. Ncgc00169074-02
34. As-56230
35. Cs-0008800
36. O0420
37. S7867
38. A12095
39. Q402625
40. Oleuropein, Primary Pharmaceutical Reference Standard
41. Brd-k08037284-001-01-4
42. Oleuropein, European Pharmacopoeia (ep) Reference Standard
43. Oleuropein, United States Pharmacopeia (usp) Reference Standard
44. (4s)-5,6-dihydro-5-ethylidene-3-(methoxycarbonyl)-6alpha-(beta-d-glucopyranosyloxy)-4h-pyran-4beta-acetic Acid 2-(3,4-dihydroxyphenyl)ethyl Ester
45. [2s-(2alpha,3e,4beta)]-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-2h-pyran-4-acetic Acid 2-(3,4-dihydroxyphenyl)ethyl Ester
46. 2h-pyran-4-acetic Acid, 3-ethylidene-2-(.beta.-d-glucopyranosyloxy)-3,4-dihydro-5-(methoxycarbonyl)-, 2-(3,4-dihydroxyphenyl)ethyl Ester, (2s-(2.alpha.,3e,4.beta.))-
47. 2h-pyran-4-acetic Acid, 5-carboxy-3-ethylidene-2-(.beta.-d-glucosyloxy)-3,4-dihydro-, 3,4-dihydroxyphenethyl 5-methyl Ester
48. Methyl (2s,3e,4s)-4-{2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxoethyl}-3-ethylidene-2-(beta-d-glucopyranosyloxy)-3,4-dihydro-2h-pyran-5-carboxylate
49. Methyl (2s,4s,e)-4-(2-(3,4-dihydroxyphenethoxy)-2-oxoethyl)-3-ethylidene-2-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2h-pyran-2-yl)oxy)-3,4-dihydro-2h-pyran-5-carboxylate
50. Methyl (4s,5e,6s)-4-[2-[2-(3,4-dihydroxyphenyl)ethoxy]-2-oxo-ethyl]-5-ethylidene-6-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-4h-pyran-3-carboxylate
Molecular Weight | 540.5 g/mol |
---|---|
Molecular Formula | C25H32O13 |
XLogP3 | -0.4 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 13 |
Rotatable Bond Count | 11 |
Exact Mass | 540.18429107 g/mol |
Monoisotopic Mass | 540.18429107 g/mol |
Topological Polar Surface Area | 202 Ų |
Heavy Atom Count | 38 |
Formal Charge | 0 |
Complexity | 873 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 7 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 1 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Antihypertensive Agents
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)
Vasodilator Agents
Drugs used to cause dilation of the blood vessels. (See all compounds classified as Vasodilator Agents.)
Anti-Infective Agents
Substances that prevent infectious agents or organisms from spreading or kill infectious agents in order to prevent the spread of infection. (See all compounds classified as Anti-Infective Agents.)
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?